ChromaDex Introduces Blood NAD+ Test Kit for Healthcare Practitioners: A Game-Changer for Personalized Aging Protocols

Healthcare practitioners now have a powerful new tool at their fingertips. ChromaDex Corp. (NASDAQ: CDXC), a leader in NAD+ research and healthy aging science, has unveiled the Niagen+ NAD+ Test Kit, exclusively designed for medical professionals seeking to measure and track patient blood NAD+ levels with unprecedented precision.

Why This Matters for Practitioners and Patients

The real challenge in NAD+ therapy has always been measurement. Without accurate baseline data and progress tracking, practitioners couldn’t truly personalize their approach. The new Niagen+ test addresses this gap head-on, enabling doctors to establish accurate NAD+ baselines before treatment and monitor changes after patients begin NAD±boosting protocols—whether through ChromaDex’s Tru Niagen oral supplements or the upcoming Niagen IV therapy administered at FDA 503B-registered clinics.

The Technology Behind the Innovation

What sets this test kit apart is its technological foundation. Unlike traditional blood spot test cards that rely on stabilizer solutions and often degrade during transport, the Niagen+ NAD+ Test Kit features a proprietary dried blood spot (DBS) card that maintains sample stability throughout the entire process. This means more reliable results, every time.

The analysis itself leverages gold-standard methodology: high-resolution liquid chromatography/tandem mass spectrometry (LC-MS/MS). Testing occurs at laboratories accredited by both the Clinical Laboratory Improvement Amendments (CLIA) and the College of American Pathologists (CAP), ensuring clinical-grade accuracy and regulatory compliance.

How the Process Works

Here’s the workflow that makes it accessible:

1. Healthcare practitioners distribute at-home test kits to patients
2. Patients register their kit on the 1health platform
3. Using the included DBS card, patients collect a blood sample and mail it back via prepaid envelope
4. Lab results arrive within approximately two weeks
5. Both practitioners and patients can access results through 1health for informed decision-making

The Product Lineup Behind the Test

ChromaDex brings significant product depth to this testing capability. Tru Niagen remains the flagship—a suite of oral supplements featuring Niagen (the patented nicotinamide riboside compound), recognized as the most efficient NAD+ precursor on the market. The company currently markets it as the number-one healthy-aging NAD+ supplement in the United States by revenue.

The ecosystem is expanding. Niagen+ pharmaceutical-grade formulations will soon be available as Niagen IV and injectable options exclusively through qualified clinics, representing a significant leap in intravenous NAD+ therapy accessibility.

Strategic Partnership Amplifies Impact

The 1health platform plays a crucial role in making this seamless. The software infrastructure connects warehouse operations, lab processing, and clinical data delivery, ensuring practitioners receive actionable insights about their patients’ NAD+ status. This integration enables truly personalized treatment protocols focused on maximizing therapeutic outcomes.

Rob Fried, CEO of ChromaDex and Founder of Tru Niagen, emphasized the market readiness: “Healthcare practitioners have consistently requested a reliable tool to measure blood NAD+ levels. We believe this represents the best measurement product currently available on the market.”

Understanding NAD+ and Its Significance

For those new to this area: NAD+ (nicotinamide adenine dinucleotide) is a vital coenzyme present in every human cell. As we age and face daily stressors, NAD+ levels naturally decline, contributing to age-related health changes and reduced vitality. Restoring NAD+ has emerged as a central focus in longevity and preventive medicine, and ChromaDex has positioned itself as the research authority in this space, collaborating with scientists and institutions globally.

What This Means Going Forward

The Niagen+ NAD+ Test Kit represents a validation of ChromaDex’s commitment to translating NAD+ science into practical clinical tools. Healthcare practitioners interested in exploring this testing capability can access comprehensive information, view the full HCP product portfolio, and review clinical research applications at www.truniagenpro.com.

For practitioners looking to shift toward data-driven, personalized aging protocols, this testing capability offers the measurement precision that informed decision-making requires.

Disclaimer: This product is not intended to diagnose, prevent, or treat medical conditions. Measurements provided are for informational and educational purposes to support general health and wellness. The product has not been tested in individuals with existing health conditions and has not received U.S. Food and Drug Administration clearance or approval.